TCWM
OVID icon

Total Clarity Wealth Management’s Ovid Therapeutics OVID Stock Holding History

Total Clarity Wealth Management’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46.6K Sell
20,975
-7,625
-27% -$13.6K 0.01% 311
2025
Q4 		$46.6K Buy
+28,600
New +$44.1K 0.01% 299

Other funds holding OVID

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Total Clarity Wealth Management's OVID Position: Q1 2026 in Review

Total Clarity Wealth Management reduced its Ovid Therapeutics (OVID) stake by 27% in Q1 2026, selling an estimated $13.6K and leaving 20,975 shares worth $46.6K. The position accounts for 0.01% of the portfolio, ranked #311.

Total Clarity Wealth Management first reported a position in OVID in Q4 2025 and has held it in 2 quarters since. The position peaked at $46.6K in Q4 2025. 103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

  • Total Clarity Wealth Management held 20,975 shares of Ovid Therapeutics worth $46.6K as of Q1 2026.
  • Total Clarity Wealth Management sold 7,625 Ovid Therapeutics shares in Q1 2026, an estimated $13.6K.
  • Ovid Therapeutics made up 0.01% of Total Clarity Wealth Management's portfolio in Q1 2026, its #311 holding.
  • Total Clarity Wealth Management first reported a position in Ovid Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Total Clarity Wealth Management's Ovid Therapeutics position peaked at $46.6K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on Total Clarity Wealth Management's 13F filing for Q1 2026, filed 17 Apr 2026.